Anna W LaVigne

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Ulcerative Colitis

Top Venues

JCO clinical cancer informatics

Journal of evaluation in clinical practice

BMJ case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sara R Alcorn, Christen R Elledge, Anna W LaVigne, Lawrence R Kleinberg, Thomas J Smith, Adam S Levin, Jacob Fiksel, Scott L Zeger, Todd McNutt, Theodore L DeWeese, Jean L Wright
Improving providers' survival estimates and selection of prognosis- and guidelines-appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform. Journal of evaluation in clinical practice 28 (4) (2022)
Sara R Alcorn, Anna W LaVigne, Christen R Elledge, Jacob Fiksel, Chen Hu, Lawrence R Kleinberg, Adam S Levin, Thomas J Smith, Zhi Cheng, Kibem Kim, Avani D Rao, Lindsey Sloan, Brandi R Page, Susan F Stinson, K Ranh Voong, Todd R McNutt, Michael R Bowers, Theodore L DeWeese, Scott L Zeger, Jean L Wright
Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment. JCO clinical cancer informatics 6 (2022)
Christen R Elledge, Anna W LaVigne, Jacob Fiksel, Jean L Wright, Todd McNutt, Lawrence R Kleinberg, Chen Hu, Thomas J Smith, Scott L Zeger, Theodore L DeWeese, Sara R Alcorn
External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases. JCO clinical cancer informatics 5 (2021)
Anna W LaVigne, Danielle N Margalit, Bhupendra Rawal, Maria Puzanov, Donald J Annino, Laura A Goguen, David J Sher, Jonathan D Schoenfeld, Nicole G Chau, Jochen H Lorch, Guilherme Rabinowits, Robert I Haddad, Roy B Tishler
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing. Head & neck 41 (4) (2019)
Anna W LaVigne, David M Meredith, David R D'Adamo, Danielle N Margalit
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity. BMJ case reports 2018 (2018)